COVID-19

Fierce Pharma

Novavax bets on ‘amplification strategy’ with Sanofi, Pfizer deals

Several other pharma companies have signed material transfer agreements so that they can experiment with Novavax's Matrix-M before committing to a deal.

Angus Liu Apr 6, 2026 8:37am

An arrow incrementally going up stairs before pointing straight up Blue background

Cyrano noses toward pivotal trial after midphase smell loss win

Feb 17, 2026 10:15am

change direction new plan alter arrows move reprioritize

AstraZeneca relaxed about relaxin drug's poor efficacy in ph. 2

Feb 10, 2026 7:50am

FDA names Tracy Beth Høeg as acting head of drug center

Dec 4, 2025 4:03am

3D rendering of SARS-CoV-2 virus particles

Dynavax pays Vaxart $30M for oral COVID-19 vaccine program

Nov 6, 2025 5:50am

Pfizer pulls the plug on 11 programs

Nov 4, 2025 2:40pm

More News

Edesa claims survival win for phase 3 respiratory failure trial

Oct 28, 2025 9:45am

Abbott device growth offsets diagnostics sales slide in Q3

Oct 15, 2025 11:00am

Fierce Pharma

ACIP narrowly votes against COVID vaccine prescriptions

Sep 19, 2025 5:22pm

Fierce Pharma

RFK Jr. blasts pharma industry, touts mRNA vaccine misinformation

Sep 4, 2025 3:51pm

See more stories